Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) TherapyChronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, hematologic disorder, leukemia, myeloid leukemia, neoplasmRecruitingNot stated2026-07-20NCT07091019

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Novartis Pharmaceuticals432

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Avera CancerSioux FallsUnited States4
Baylor Scott and White ResearchTempleUnited States3
Cancer Care Specialists of Central IllinoisDecaturUnited States3
Fred Hutchinson Cancer Research CenterSeattleUnited States4
Lundquist Inst BioMed at HarborTorranceUnited States5
MultiCare Health System InstituteTacomaUnited States1
Northwest Medical SpecialtiesTacomaUnited States32
NY Cancer and Blood SpecialistsEast SetauketUnited States1
Oregon Oncology Specialists SalemSalemUnited States2
Sacred Heart Medical OncologyPensacolaUnited States1
St Agnes HospitalBaltimoreUnited States1
Stamford HospitalStamfordUnited States7
Stockton Hematology Oncology Medical Group IncStocktonUnited States1
SUNY Upstate Medical UniversitySyracuseUnited States68
Tri-County Hematology and Oncology AssociatesCantonUnited States1
Truman Medical CenterKansas CityUnited States6
University of Alabama at BirminghamBirminghamUnited States3